Drug Testing Locations - Mena, AR

Drug Testing in Mena, AR

Mena, Arkansas Statistics

Mena, located in Polk County, AR, has seen a 12% increase in drug-related arrests over the past year.

In Polk County, opioid prescriptions peaked at 89% of the population, according to a 2022 report.

Mena's rehabilitation facilities have reported a 15% rise in admissions for drug abuse.

In Mena, AR, drug-related ER visits have increased by 10% since last year.

Polk County's Drug Court has expanded its program by 20% to accommodate increasing drug offenses.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Mena, AR & Drug Testing Policies

Employers in Mena, AR, are increasingly implementing stringent drug testing policies to combat workplace drug abuse. Incorporating regular and random drug tests, many businesses aim to maintain a safe and productive environment. According to the Department of Labor, workplace policies must comply with state and federal guidelines while ensuring employee rights are respected.

Local companies often use third-party services to conduct these drug tests, ensuring objectivity and compliance. Furthermore, employers provide assistance through employee assistance programs (EAPs), offering counseling and rehabilitation options for employees who may need support in overcoming drug-related challenges.

Government Efforts with Drug Problems in Mena, AR

The government of Mena, AR, in Polk County, is actively addressing drug abuse through various initiatives. Local authorities have partnered with the Drug Court of the Western Arkansas to provide specialized programs focusing on rehabilitation and prevention. Efforts include community education, increased policing, and enhanced treatment options for those struggling with addiction.

Additionally, the state government collaborates with local efforts by offering support through the Arkansas Department of Health's Substance Abuse Prevention Program. This program supports local initiatives focused on early intervention and reducing drug-related crime rates in the region, ensuring a holistic approach to tackling the drug issue.

Local Drug Busts & News in Mena, AR

Mena, AR, has recently witnessed several local drug busts as part of a concerted effort by law enforcement to combat drug-related activities. In a significant event earlier this year, the Polk County Sheriff's Office conducted an operation that led to multiple arrests and the seizure of illegal substances.

These efforts highlight the commitment of local authorities to tackle the drug problem in Mena. Such operations often involve coordination with state-level agencies to ensure comprehensive law enforcement and community safety. Cooperation between law enforcement and community members is crucial in reducing the prevalence of drug activities in the region.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Mena, AR. Trusted by employers nationwide for accurate results and exceptional service.

Arkansas DOT/Non DOT Physicals

Arkansas Vision Tests

Arkansas Audiograms

Arkansas Respirator Fit Tests

Arkansas Lift Tests

Arkansas Background Checks

Clinical Testing Services

TB Testing in AR

Diabetes Testing in AR

Infectious Disease Testing in AR

Sickle Cell Anemia Testing in AR

Women/Men's Health Testing in AR

Resources & Citations

Arkansas Department of Health: Substance Abuse and Prevention

Arkansas Department of Human Services: Behavioral Health

Mena Regional Health System

Arkansas National Guard Counterdrug Program

NAADAC Arkansas

Polk County Recovery Rally

Arkansas Rural Health Partnership

Arkansas Counseling Association

The Smith Clinic for Physical Therapy

Drug Testing Near Mena, AR

Grannis, AR

Cauthron, AR

Waldron, AR

Umpire, AR

Parks, AR

Scott, AR

Wickes, AR

Boles, AR

Black Fork, AR

Big Fork, AR

Vandervoort, AR

Y City, AR

Hatfield, AR

Board Camp, AR

Potter, AR

Frequently Asked Questions

Customer Reviews